Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Moleculin Announces Additional Positive Interim Results from Studies of Annamycin in AML

americanpharmaceuticalreviewDecember 10, 2019

Tag: Moleculin , Annamycin , AML

PharmaSources Customer Service